GPOVY Stock | News | Quote | Stock Forum | Friday, October 25,

New Post Public Reply Private Reply Replies (0) Message Board
Rosner
Grupo Carso S.A. de CV GPOVY Company Overview 

Stock Message Board http://investorshangout.com/search?q=GPOVY&am...mp;yt1=Go!

Last Updated: Friday, October 25, 2013 8:27:49 PM

Grupo Carso S.A. de CV GPOVY Current Price and Quotes
Last Price 10.64
Previous Close 10.64 Open N/A
Daily Range N/A - N/A 52wk Range 12.22 - 7.18
Volume 0 Dividend 0.0982
Average Vol (3m) 1,443 Yield 0.922932
Grupo Carso S.A. de CV GPOVY
Company Information

Miguel de Cervantes Saavedra
255, Colonia Ampliación Granada
Mexico D.F. 11520
Mexico

Website: http://www.gcarso.com.mx
Phone: +52-55-5328-5800

Grupo Carso S.A. de CV GPOVY
Grupo Carso SAB de CV is a Mexico-based conglomerate engaged, through its subsidiaries, in the industrial, retail, infrastructure and construction sectors, as well as in the automotive industry. Its business is structured in four divisions: Industrial, which comprises the operations of Grupo Condumex SA de CV, a manufacturer of electrical conductors mainly used in the telecommunications, automotive and energy sectors; Retail, which includes the activities of Grupo Sanborns SA de CV, an owner of...



Grupo Carso S.A. de CV GPOVY
Financial Reportings and Disclosures

Reporting Status International Reporting: Bolsa Mexicana de Valores
CIK 0000882740
Fiscal Year End 12/31
OTC Marketplace OTC Pink Current
Profile Data

SIC - Industry Classification 8880 - American Depositary Receipts
Incorporated In: Mexico
Year of Inc. 1980
Employees Not Available
Company Officers/Contacts

J. Humbeto Olvera- Zubizarre CEO
Angélica Piña Garnica IR
Company Directors

Carlos Slim Domit Chairman
Service Providers

Auditor/Accountant
Not Available
Legal Counsel
Not Available
Investor Relations Firm
Not Available

Grupo Carso S.A. de CV GPOVY
GPOVY Security Details Other Company Securities

Share Structure

Market Value1 $12,246,608,080 a/o Oct 24, 2013
Shares Outstanding 2,301,994,000 a/o Feb 28, 2011
Float Not Available
Authorized Shares Not Available
Par Value  No Par Value
Shareholders

Shareholders of Record Not Available
Corporate Actions

Ex. Date Record Date Pay Date
Dividend (0.59832) Oct 31, 2013 Nov 04, 2013 Nov 14, 2013
Dividend (0.04768) Oct 24, 2013 Oct 28, 2013 Oct 31, 2013
Dividend (0.05057) May 09, 2013 May 13, 2013 May 24, 2013
Security Notes

Capital Change=shs increased by 3 for 1 split. Ex-date=05/23/2005. Rec date=05/19/2005. Pay date=05/20/2005.
Non US Stock Exchange Listing

GCARSOA1 - Bolsa Mexicana de Valores - Qualified
Short Selling Data

Short Interest 223,207 (-0.45%)
Sep 30, 2013
Significant Failures to Deliver  No
Transfer Agent(s)

BNY Mellon

Grupo Carso S.A. de CV GPOVY Financials
GPOVY


Grupo Carso S.A. de CV GPOVY Recent News

GPOVY Grupo Carso S.A. de CV Research DD Guide

Stock Message Board http://investorshangout.com/search?q=GPOVY&am...mp;yt0=Go!
Stock Quote http://www.otcmarkets.com/stock/GPOVY/quote
Stock Chart http://www.otcmarkets.com/stock/GPOVY/chart
Company Info http://www.otcmarkets.com/stock/GPOVY/company-info
Recent News http://www.otcmarkets.com/stock/GPOVY/news
Financials http://www.otcmarkets.com/stock/GPOVY/financials
Filings and Disclosure http://www.otcmarkets.com/stock/GPOVY/filings
Short Sales http://www.otcmarkets.com/stock/GPOVY/short-sales
Insider Disclosure http://www.otcmarkets.com/stock/GPOVY/insider-transactions
Research Reports http://www.otcmarkets.com/stock/GPOVY/research
Summary http://finance.yahoo.com/q?s=GPOVY
Historical Prices http://finance.yahoo.com/q/hp?s=GPOVY+Historical+Prices
Interactive Chart http://finance.yahoo.com/echarts?s=GPOVY
Basic Chart http://finance.yahoo.com/q/bc?s=GPOVY+Basic+Chart
Basic Tech. Analysis http://finance.yahoo.com/q/ta?s=GPOVY+Basic+Tech.+Analysis
Headlines http://finance.yahoo.com/q/h?s=GPOVY+Headlines
Press Releases http://finance.yahoo.com/q/p?s=GPOVY+Press+Releases
Company Profile http://finance.yahoo.com/q/pr?s=GPOVY+Profile
Key Statistics http://finance.yahoo.com/q/ks?s=GPOVY+Key+Statistics
Industry http://finance.yahoo.com/q/in?s=GPOVY+Industry
Major Holders http://finance.yahoo.com/q/mh?s=GPOVY+Major+Holders
Insider Transactions http://finance.yahoo.com/q/it?s=GPOVY+Insider+Transactions
Insider Roster http://finance.yahoo.com/q/ir?s=GPOVY+Insider+Roster
Income Statement http://finance.yahoo.com/q/is?s=GPOVY
Balance Sheet http://finance.yahoo.com/q/bs?s=GPOVY
Cash Flow http://finance.yahoo.com/q/cf?s=GPOVY+Cash+Flow&annual
Nasdaq http://www.nasdaq.com/symbol/GPOVY
Market Watch http://www.marketwatch.com/investing/stock/GPOVY
Bloomberg http://www.bloomberg.com/quote/GPOVY:US
Morningstar http://quotes.morningstar.com/stock/s?t=GPOVY
Bussinessweek http://investing.businessweek.com/research/st...cker=GPOVY
Barchart http://www.barchart.com/quotes/stocks/GPOVY
OTC Short Report http://otcshortreport.com/index.php?index=GPOVY
Investopedia http://www.investopedia.com/markets/stocks/GPOVY/?wa=0

List of all stock message boards and tickers for OTC BB Pinks & Penny Stocks http://investorshangout.com/board?categoryid=OTC
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Hugel's Sales Climb Despite Changes in Sales Models

Updated Category News Views 97

Hugel's Financial Fortunes in a Shifting Landscape Who would've thought? That’s the vibe hugging the numbers Hugel Inc. just dropped. Their performance for the first three quarters of 2026 is in the books, and results show consolidated net sales climbing 15% year-on-year. Just how did they pull this rabbit out of the hat? Let's dissect this a bit. Cracking the Code of...

Continue Reading
Are BWIN, LFCR, PCRX Shareholder Deals Fair?

Updated Category News Views 100

What's Really Going On with BWIN, LFCR, and PCRX? Everyone talks about when there's smoke, there's fire. But in this case, it’s hard not to wonder if we're standing knee-deep in burning embers, or just a dusty old campfire. Halper Sadeh LLC is ringing the alarm bells for Baldwin Group, Lifecore Biomedical, and Pacira BioSciences, the trio tagged under NASDAQ: BWIN,...

Continue Reading
MRP Securities Fraud: Investors Eye Millrose Case

Updated Category News Views 104

Millrose's Troubles: A Closer Look at the Fraud Accusation Now, here's a pickle. Millrose Properties, Inc. (NYSE: MRP) has landed itself in hot water. We've got a bona fide class action lawsuit on our hands, and Schall, Brown & Schwartz LLP is waving the flag, rallying investors to step up and face the music. Turns out the company's talk might not have walked the walk...

Continue Reading
Peabody's Q3 2026: Margins Climb Despite Net Loss

Updated Category News Views 0

Tough Quarters but Promising Margins Alright, Peabody's Q3 2026 isn't the most sunshine-filled report I've laid eyes on, but it's not all shadows either. Sure, they posted a net loss of $32.8 million, better than last year's $70.1 million drain. Admit it or not, that's improvement. And yet, the real gem here is those expanding margins gleaming despite the loss-heavy...

Continue Reading
Omnissa Expands AI Sovereignty: New Markets, New Control

Updated Category News Views 41

Omnissa Rolls Out AI Sovereignty Across New Markets In the world of AI, where data is king and control is the crown, Omnissa is making bold moves with its latest expansion announcement. The company's Sovereign Solution (OSS) is now reaching into six fresh markets across Europe and Asia, offering organizations a vital grip on their digital domains like never before. Talk...

Continue Reading
UN Forum Unleashes LatAm CEO Coalition for Action

Updated Category News Views 89

Latin America Takes Center Stage When the UN turns its spotlight on a region, you know there's something afoot. Right in Montevideo, Uruguay, the United Nations Global Compact gathered a hefty crowd of over 300 leaders from diverse backgrounds—think business, finance, government, and academia. What they were brewing wasn’t just talk; it was about driving real change...

Continue Reading
Lincoln Index Highlights Growth, But Risks Linger

Updated Category News Views 130

Private Market Dynamics: A Mixed Bag in Q3 The Lincoln Private Market Index (LPMI) is giving us quite the mixed message this quarter. Up by 2.8%, the index is applauding earnings growth in private companies. Not too shabby, right? Yet, let's not pop the champagne just yet. It's not all sunshine and roses—credit risk clouds are looming large. Steady Performers, but Not...

Continue Reading
Lumentum Holders Question Marvell Deal Fairness: Legal Eyes

Updated Category News Views 82

What's Brewing with Lumentum and Marvell? There's no denying the chatter on Wall Street when there's a potential shake-up, especially with a big merger at stake. We're staring down the barrel of an investigation concerning Lumentum Holdings Inc. (NASDAQ: LITE) and Marvell Technology, Inc.'s deal. The M&A Class Action Firm, helmed by Juan Monteverde, is the name leading...

Continue Reading
Fluence Energy Faces Legal Trouble: A Closer Look

Updated Category News Views 31

Fluence Energy's Legal Tangle: What It Means for Investors You ever get that gut punch feeling when a company you’re watching stumbles? Well, Fluence Energy, Inc. (NASDAQ: FLNC) seems to have handed that to its shareholders lately. There's a class action lawsuit out there that’s got investors not only scratching their heads but also reaching for their phones. The...

Continue Reading
EXPO 2027 Belgrade: Serbia's Tourism Game-Changer?

Updated Category News Views 104

An Unexpected Stage: Belgrade's Big Show Well, who's betting on Belgrade making waves in the global travel scene? EXPO 2027 is shaping up to do just that, and it’s taking the scenic route. Serbia, a country not always on the grand tourist itineraries, could finally hog the spotlight come 2027. Under the banner of 'Play for Humanity: Sport and Music for All,' they're...

Continue Reading

Top 5 Most Recently Viewed Articles

Exploring the Latest Trends in Alcohol Policy and Health Advances

Updated Category News Views 436

Exploring the Latest Trends in Alcohol Policy and Health Advances Alcohol Justice has unveiled its February 2025 eNews, delivering a thorough overview of significant news, research, and advocacy surrounding the effects of alcohol on communities and public health. This month’s publication emphasizes vital advancements in the sphere of alcohol policy, paying close...

Continue Reading
Explore the Exciting New Manor Collection at Sereno Canyon

Updated Category News Views 273

Announcing the Grand Opening of the Manor Collection Exciting news is on the horizon as Toll Brothers, Inc. (NYSE:TOL), the nation’s leading luxury home builder, proudly presents the grand opening of its new Manor Collection at Sereno Canyon. This exceptional community is nestled in the breathtaking landscape of Scottsdale and offers residents a blend of luxury,...

Continue Reading
Federal Home Loan Bank of Boston Reports Strong Financial Results

Updated Category News Views 170

Federal Home Loan Bank of Boston Reports 2024 Results The Federal Home Loan Bank of Boston declared its preliminary financial results for the fourth quarter and the year 2024. The Bank reported a significant net income of $82.1 million for the last quarter of 2024, contributing to an impressive annual total of $290.5 million. These results are expected to be highlighted...

Continue Reading
Understanding the Rising Short Interest in IBM Stock

Updated Category News Views 133

Understanding the Rising Short Interest in IBM Stock IBM's short interest has significantly increased, recently rising by 12.5%. Currently, there are 23.16 million shares that have been sold short, representing 2.52% of the total shares available for trading. With this level of short interest, it would take traders approximately 5.94 days to cover their short positions...

Continue Reading
AlphaTON and ADDRI Join Forces for Mesothelioma Clinical Research

Updated Category News Views 144

Exciting New Clinical Trial Initiative for Mesothelioma AlphaTON Capital Corp (NASDAQ: ATON) has made a significant stride in the fight against mesothelioma by partnering with Australia's Asbestos and Dust Diseases Research Institute (ADDRI). Together, they are setting the stage for an investigator-initiated clinical trial to evaluate TT-4, a promising selective A2B...

Continue Reading